Cabaletta Bio (NASDAQ:CABA) Rating Reiterated by Cantor Fitzgerald
Cantor Fitzgerald restated their overweight rating on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a report published on Friday, Benzinga reports. They currently have a $50.00 price target on the stock. Several other brokerages also recently weighed in on CABA. William Blair restated an outperform rating and set a $38.00 price objective on […]